Upgrade to remove ads
Only $35.99/year

NR 508 Week 2 Chamberlain

Terms in this set (72)

Men who use transdermal testosterone gel (AndroGel) should be advised to avoid:
1. Washing their hands after applying the gel
2. Wearing occlusive clothing while using the gel
3. Exposure to estrogens while using the gel
4. Skin-to-skin contact with pregnant women while using the gel
4. Skin-to-skin contact with pregnant women while using the gel
Education when prescribing androgens to male patients includes advising that:
1. Short-term use places the patient at risk for hepatocellular carcinoma.
2. Cholestatic hepatitis and jaundice may occur with low doses of androgens.
3. Gynecomastia is a rare occurrence with the use of androgens.
4. Low sperm levels only occur with long-term use of androgens.
2. Cholestatic hepatitis and jaundice may occur with low doses of androgens.
Patients who are prescribed exogenous androgens need to be warned that decreased libido:
1. Is an unusual side effect of androgens and should be reported to the provider
2. Is treated with increased doses of androgens, so the patient should let the provider know if he is having problems
3. May be a sign of early prostate cancer and he should make an appointment for a prostate screening exam
4. May occur with androgen therapy
4. May occur with androgen therapy
The U.S. Food and Drug Administration warns that androgens may cause:
1. Peliosis hepatis
2. Orthostatic hypotension
3. Menstrual irregularities
4. Acne
1. Peliosis hepatis
Monitoring for a patient who is using androgens includes evaluation of:
1. Complete blood count and C-reactive protein levels
2. Lipid levels and liver function tests
3. Serum potassium and magnesium levels
4. Urine protein and potassium levels
2. Lipid levels and liver function tests
Male patients require ______________________ before and during androgen therapy.
1. A digital prostate exam
2. A Doppler exam of testicular blood flow
3. Urine analysis for proteinuria
4. Serial orthostatic blood pressures
1. A digital prostate exam
Absolute contraindications to estrogen therapy include:
1. History of any type of cancer
2. Clotting disorders
3. History of tension headaches
4. Orthostatic hypotension
2. Clotting disorders
Postmenopausal women with an intact uterus should not be prescribed:
1. Estrogen/progesterone combination
2. IM medroxyprogesterone (Depo Provera)
3. Estrogen alone
4. Androgens
3. Estrogen alone
Women who have migraines with an aura should not be prescribed estrogen because of:
1. The interaction between triptans and estrogen, limiting migraine therapy choices
2. An increased incidence of migraines with the use of estrogen
3. An increased risk of stroke occurring with estrogen use
4. Patients with migraines may be prescribed estrogen without any concerns
3. An increased risk of stroke occurring with estrogen use
A 22-year-old woman receives a prescription for oral contraceptives. Education for this patient includes:
1. Counseling regarding decreasing or not smoking while taking oral contraceptives
2. Advising a monthly pregnancy test for the first 3 months she is taking the contraceptive
3. Advising that she may miss two pills in a row and not be concerned about pregnancy
4. Recommending that her next follow-up visit is in 1 year for a refill and annual exam
1. Counseling regarding decreasing or not smoking while taking oral contraceptives
A 19-year-old female is a nasal Staph aureus carrier and is placed on 5 days of rifampin for treatment. Her only other medication is combined oral contraceptives. What education should she receive regarding her medications?
1. Separate the oral ingestion of the rifampin and oral contraceptive by at least an hour.
2. Both medications are best tolerated if taken on an empty stomach.
3. She should use a back-up method of birth control such as condoms for the rest of the current pill pack.
4. If she gets nauseated with the medications she should call the office for an antiemetic prescription.
3. She should use a back-up method of birth control such as condoms for the rest of the current pill pack.
A 56-year-old woman is complaining of vaginal dryness and dyspareunia. To treat her symptoms with the lowest adverse effects she should be prescribed:
1. Low-dose oral estrogen
2. A low-dose estrogen/progesterone combination
3. A vaginal estradiol ring
4. Vaginal progesterone cream
3. A vaginal estradiol ring
Shana is receiving her first medroxyprogesterone (Depo Provera) injection. Shana will need to be monitored for:
1. Depression
2. Hypertension
3. Weight loss
4. Cataracts
1. Depression
When prescribing medroxyprogesterone (Depo Provera) injections, essential education would include advising of the following potential adverse drug effects:
1. Hypertension and dysuria
2. Depression and weight gain
3. Abdominal pain and constipation
4. Orthostatic hypotension and dermatitis
2. Depression and weight gain
The medroxyprogesterone (Depo Provera) injection has a Black Box Warning due to:
1. The potential development of significant hypertension
2. Increased risk of strokes
3. Decreased bone density
4. The risk of a life-threatening rash such as Stevens-Johnson
3. Decreased bone density
Sets with similar terms